The Latest Breaking News from Obesity

Men’s average testosterone levels have halved in last 50 years, say scientists

Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes

The Guardian - UK · Jul 7

A New FDA-Approved Oral Weight Loss Pill Requires No Fasting: What Makes Foundayo Different from Other GLP-1 Drugs

FDA approved Foundayo (orforglipron) on April 1, 2026 — the only oral GLP-1 pill for weight loss you can take any time of day without fasting. Average weight loss: 12.4%. Here's the breakdown.

Medical Daily · Jul 7

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

MarketBeat · Jul 6

Food Processing Minister Chirag Paswan asks food cos to focus on making quality products

Union Minister Chirag Paswan underscored the potential within India's food processing industry, encouraging businesses to focus on quality to compete in international markets. He raised alarms about the increasing obesity rates among young people, advocating for healthier snack options.

The Economic Times · Jul 3

Women Are Getting Hired More After Losing Weight on GLP-1 Drugs: A New Study Raises Difficult Questions

A new study found GLP-1 drug users hired more after weight loss — but researchers say the finding reflects illegal-in-most-states weight discrimination, not just health gains.

Medical Daily · Jul 3

Scientists Just Found Why Middle-Age Belly Fat Suddenly Appears, and It Has to Do with Stem Cells

New research published June 27 found aging-activated stem cells drive middle-age belly fat accumulation. The same visceral fat is linked to heart disease and Alzheimer's risk.

Medical Daily · Jul 3

“​​GLP-1s are changing obesity care, but they’ve also created unrealistic expectations”—the CEO of the American Council on Exercise on common weight loss misconceptions

Treating GLP-1s as a substitute for lifestyle change is one of the most common mistakes people make, says this industry expert

Fit & Well · Jul 2

Medicare's New $50 GLP-1 Weight-Loss Program Just Launched: Find Out if You Qualify

Medicare's GLP-1 Bridge launched July 1, 2026. Up to 3.8M seniors may qualify for $50/month Wegovy, Zepbound, or Foundayo. Here's the eligibility breakdown.

Medical Daily · Jul 2

Obese adults heart attack risk now similar to slim people thanks to widespread use of statins, study finds

Statins, a cholesterol lowering drug taken by about 8 million people in the UK, could be narrowing the heart attack risk between obese adults and those of a healthy weight

The Independent UK · Jul 2

Four GLP-1 Findings from June 2026 Are Changing the Picture of What These Drugs Actually Do

Four GLP-1 studies published in June 2026 show effects on breast cancer, violence, bone fractures, and physical activity. Here's what each found and what it means for patients.

Medical Daily · Jun 30